NCT06180941View on ClinicalTrials.gov

Adjuvants for Bupivacaine in Brachial Plexus Block in Pediatrics

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions
Upper Limb Injury
Interventions
DRUG

magnesium sulfate.

magnesium sulfate as adjuvant to bupivacaine in supraclavicular brachial plexus block in pediatrics.

DRUG

clonidine.

clonidine as adjuvant to bupivacaine in supraclavicular brachial plexus block in pediatrics.

All Listed Sponsors
lead

Assiut University

OTHER

NCT06180941 - Adjuvants for Bupivacaine in Brachial Plexus Block in Pediatrics | Biotech Hunter | Biotech Hunter